Expanding Access to Therapy for Childhood Anxiety Disorders Via Smart Phones - RCT
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Anxiety
- Sponsor
- Stephen Whiteside
- Enrollment
- 145
- Locations
- 1
- Primary Endpoint
- Mean change from Baseline in Pediatric Anxiety Rating Scale (PARS) at Treatment Completion
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
This research study aims to test the feasibility and effectiveness of using the Mayo Clinic Anxiety Coach smartphone app as an addition to traditional therapy for the treatment of anxiety disorders in youth, particularly those youth who may have limited access to mental health treatment in the traditional clinical setting.
Detailed Description
60 therapists in underserved areas will treat children with anxiety disorders in one of three conditions (treatment as usual, Anxiety Coach with face-to-face therapy, or Anxiety Coach with minimal direct contact) to determine the feasibility of using of Anxiety Coach to increase the frequency of exposure and improve outcomes with varying degrees of face-to-face contact (N = 60 patients).
Investigators
Stephen Whiteside
Professor of Psychology
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
- •Age 7 to 17
- •Primary diagnosis of:
- •social phobia,
- •separation anxiety disorder,
- •panic disorder with and without agoraphobia,
- •specific phobia, or
- •obsessive compulsive disorder
- •A parent or other primary care giver available to participate with the child in all assessment and treatment activities
- •Estimated average intelligence
- •English speaking
Exclusion Criteria
- •History of and/or current diagnosis of:
- •bipolar disorder,
- •mental retardation,
- •oppositional defiant disorder,
- •selective mutism, or
- •major depressive disorder
- •Current suicidality or recent suicidal behavior
- •Parent to be involved in study who is unable to adequately participate due to intellectual or psychiatric difficulties
- •Starting or changing the dosage of a psychiatric medication in the last two months
Outcomes
Primary Outcomes
Mean change from Baseline in Pediatric Anxiety Rating Scale (PARS) at Treatment Completion
Time Frame: Within 5 working days of Treatment Completion
The Pediatric Anxiety Rating Scale (PARS) is an interview-based tool used to assess for the presence and severity of anxiety symptoms in children and adolescents utilizing parental and youth input to guide clinician ratings.